Clinical trial Recruiting at 1 site Interventional Ages 18 to 42 Women only

Test to predict pregnancy chances for IVF patients

Official title: Innovation for Small-scale Experiments: ReceptIVFity Test

Run by Erasmus Medical Center · NCT06051201 · Data updated 2026-11-12

This study is testing a new way to predict the chances of getting pregnant through IVF by looking at the vaginal bacteria in women aged 18 to 43.

Quick facts

Study typeInterventional
Ages18 Years to 42 Years
SexWomen only
Enrollment683 (estimated)
SponsorErasmus Medical Center
Academic / other
Locations1 site (Rotterdam)
StatusRecruiting
StartedSeptember 4, 2023
Main results expectedSeptember 2026
Study endsSeptember 2027
Registry record updatedSeptember 19, 2024
Trial IDNCT06051201 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are naïve IVF or IVF-ICSI patients aged 18 to 43 who are willing to provide a vaginal swab for the ReceptIVFity test.

Probably not a fit

Patients currently using hormonal contraceptives or antibiotics, or those requiring emergency IVF for cancer, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ReceptIVFity test evaluates the vaginal microbiome to predict the success rate of IVF or IVF-ICSI treatments. This prospective, non-invasive randomized controlled study aims to compare Shared Decision Making with Physician Decision in determining the likelihood of successful pregnancies. It includes an observational arm for women of non-European origin and focuses on naïve IVF patients aged 18 to 43. The study seeks to reduce unnecessary treatment cycles and improve the efficacy of IVF procedures.

Why it matters

Potential benefit: If successful, this test could enhance the chances of achieving pregnancy for IVF patients by providing tailored treatment recommendations.

How similar studies have gone: Other studies have shown promise in using microbiome assessments to improve IVF outcomes, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Naïve IVF or IVF/ICSI patients
2. Indication for an IVF or IVF-ICSI procedure.
3. 18 years \< age \< 43 years.
4. Willing to provide a vaginal swab with the ReceptIVFity test.
5. Willing to provide informed consent.

Exclusion Criteria:

1. The use of hormonal contraceptives at the time of taking the test.
2. The use of antibiotic treatment at the time of taking the test.
3. Emergency IVF for cancer or other reasons.
4. Women with endometriosis pre-treated with an Gn-RH analogue.
5. Women having IVF for egg preservation reasons.

Where it's running

  • Erasmus University Medical Center
    Rotterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.